• Saquinavir Workflows for Protease and Membrane Studies

  2026-08-13

  Build more informative Saquinavir experiments by pairing direct HIV protease inhibition assays with biomimetic membrane-partitioning measurements. This workflow shows when IAM LC or LEKC is the better choice, how to control DMSO and pH effects, and how to troubleshoot weak or misleading signals.

• 10058-F4: A Better Way to Read c-Myc Biology

  2026-08-13

  10058-F4 is a c-Myc-Max dimerization inhibitor that can reveal how transcriptional disruption becomes cell-cycle arrest, mitochondrial apoptosis, or differentiation. This article presents an assay-centered framework connecting c-Myc perturbation with the APEX2–TERT findings while clearly separating established evidence from testable hypotheses.

• Optimized hiPSC Differentiation for Functional Platelets

  2026-08-12

  A 2026 study in Stem Cell Reviews and Reports presents an optimized differentiation scheme for producing megakaryocytes and functional platelets from human induced pluripotent stem cells. By increasing embryoid body input, using human platelet lysate, replacing selected cytokines with small molecules, and promoting megakaryocyte maturation, the protocol improved yield, shortened production time, and reduced reported costs.

• Fluo-4 AM for Mechanotransduction Assays

  2026-08-12

  Connect fiber-density engineering with live-cell calcium readouts using a sensitive, no-wash workflow. The approach supports both mechanotransduction studies in annulus fibrosus cells and scalable GPCR inhibitor or agonist screening.

• Berbamine hydrochloride Workflows for Ferroptosis

  2026-08-11

  Build a controlled workflow for testing Berbamine hydrochloride across leukemia and hepatocellular carcinoma models, while separating pathway modulation from ferroptotic cell death. The approach combines product-handling guidance with the METTL16–SENP3–LTF findings to improve assay design, comparison, and troubleshooting.

• Pol II Degradation and Transcription-Independent Death

  2026-08-11

  The preprint argues that targeted degradation of RNA polymerase II can activate cell death without requiring global transcriptional shutdown, separating Pol II loss from the conventional assumption that death follows transcriptional collapse. This distinction provides a useful framework for interpreting apoptosis mechanisms and for designing experiments that independently measure protein degradation, transcription, and cell-death execution.

• Entinostat (MS-275) Workflow for Cancer Assays

  2026-08-10

  Entinostat (MS-275) combines HDAC1/3-biased epigenetic modulation with a practical platform for separating growth arrest from true cell killing. This workflow shows how to optimize dosing, pair viability with death and acetylation readouts, and translate findings cautiously into retinoblastoma research and solid tumor studies.

• JNJ-26854165 (Serdemetan): p53 Research Guide

  2026-08-09

  JNJ-26854165, also called Serdemetan, is a small-molecule HDM2 ubiquitin ligase antagonist for preclinical cancer research. Its reported activity includes p53 pathway modulation, cell-proliferation inhibition, endothelial migration inhibition, and enhancement of radiation-induced tumor growth delay in xenografts.

• Cy3 TSA Fluorescence System Kit Workflow

  2026-08-08

  Build a sensitive, microscopy-ready workflow for IHC, ICC, and ISH when conventional fluorescence produces weak or ambiguous signals. This guide connects Cy3 tyramide deposition with spatial proteomics, showing where the kit adds localization confidence and where it should not be mistaken for a proteomic measurement.

• Primidone Workflows for TRPM3 and RIPK1

  2026-08-07

  Primidone (Mysoline) offers a practical bridge between TRPM3 channel assays and RIPK1-centered neurodegeneration research. This guide converts its biochemical profile into reproducible cell, animal, and biomarker workflows, with dosing logic and troubleshooting for translational studies.

• MDM1 Overexpression Sensitizes Colorectal Cancer to Chemorad

  2026-08-07

  The referenced study establishes MDM1 as a key regulator of p53-mediated apoptosis, enhancing chemoradiotherapy sensitivity in colorectal cancer. These findings provide mechanistic insight and position MDM1 as a predictive biomarker and potential intervention target for overcoming treatment resistance.

• Myriocin as a Precision Tool: Advancing Sphingolipid Metabol

  2026-08-06

  Explore the multifaceted roles of Myriocin, a potent serine palmitoyltransferase inhibitor, in sphingolipid metabolism research. This article uniquely dissects its systemic impact on metabolic homeostasis, offering critical insights for advanced assay design.

• VX-765: Precision Caspase-1 Inhibition for Translational Dis

  2026-08-06

  Explore how VX-765, a selective caspase-1 inhibitor, empowers advanced translational disease models by enabling precise modulation of IL-1β and IL-18 release. This article uniquely bridges mitochondrial apoptotic pathways with practical assay design, offering actionable guidance for inflammation and pyroptosis research.

• Caspase-8 Fluorometric Assay Kit: Precision in Apoptosis Ass

  2026-08-05

  Unlock sensitive, quantitative detection of Caspase-8 activity with APExBIO’s Caspase-8 Fluorometric Assay Kit. This guide connects mechanistic advances in cell death research to stepwise protocols, advanced applications, and troubleshooting strategies, empowering apoptosis and neurodegenerative disease studies.

• Panobinostat (LBH589): Driving Epigenetic-Driven Synergy in

  2026-08-05

  Explore how Panobinostat (LBH589), a potent HDAC inhibitor, enables breakthrough synergy in epigenetic regulation research and advanced cancer model systems. Discover mechanistic insights and practical guidance not found in standard protocols.

537 records 7/36 page Previous Next First page 上5页 678910 下5页 Last page